Advanced Medical Therapies in the Management of Non-Scarring Alopecia: Areata and Androgenic Alopecia

    Antonio Martínez-López, Trinidad Montero-Vilchez, Álvaro Sierra-Sánchez, Alejandro Molina-Leyva, Salvador Arias-Santiago
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This review article summarizes the potential role of advanced medical therapies—using genes, cells, and/or tissue engineering—in treating various types of alopecia, by examining clinical research, basic studies, and ongoing trials.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The review "Advanced Medical Therapies in the Management of Non-Scarring Alopecia: Areata and Androgenic Alopecia" discusses the potential of advanced therapies, such as gene, cell, and tissue engineering therapies, in treating alopecia areata and androgenic alopecia. The document highlights the potential of human mesenchymal stem cells (hMSCs) in regenerative medicine, including their application in dermatology for repairing and regenerating skin abnormalities. Various studies are discussed, including those involving the use of mesenchymal stem cells (MSCs), adipose cells, and gene therapy. Results show promising hair regrowth and improvement in alopecia conditions, with one study even regenerating 225 hair follicles from one hair follicle donor tissue. However, the authors conclude that while these therapies show promise in preclinical studies, more clinical studies are needed to verify their safety and effectiveness for diverse forms of non-scarring alopecia.
    Discuss this study in the Community →

    Research cited in this study

    36 / 36 results